| 前收市價 | 241.23 |
| 開市 | 241.49 |
| 買盤 | 242.73 x 800 |
| 賣出價 | 242.88 x 800 |
| 今日波幅 | 241.30 - 243.55 |
| 52 週波幅 | 215.90 - 277.29 |
| 成交量 | |
| 平均成交量 | 1,113,920 |
| 市值 | 68.943B |
| Beta 值 (5 年，每月) | 0.56 |
| 市盈率 (最近 12 個月) | 46.79 |
| 每股盈利 (最近 12 個月) | 5.19 |
| 業績公佈日 | 2023年5月03日 - 2023年5月08日 |
| 遠期股息及收益率 | 3.64 (1.51%) |
| 除息日 | 2023年3月09日 |
| 1 年預測目標價 | 274.00 |
- InvestorPlace
The 7 Best Dividend Growth Stocks for Long-Term Investors
When faced with myriad market ambiguities, investors may be well served to target the best dividend growth stocks to buy. In many ways, this investment category represents the best of both worlds. Fundamentally, passive-income providers typically align with established (and therefore profitable) businesses. Since the market can go either way under ambiguous cycles, dividend providers offer a hedge. However, pure passive-income plays don’t offer much upside return. On the other hand, growth-orien
- Insider Monkey
15 Best Safe Dividend Stocks For 2023
In this article, we discuss the 15 best safe dividend stocks for 2023. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read the 5 Best Safe Dividend Stocks For 2023. When things get rough for Wall Street, many smart investors turn towards safe dividend […]
- Benzinga
Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software
Becton Dickinson and Co (NYSE: BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software. Alaris Infusion Central, a standalone software — separate from pumps — provides data from the Alaris pumps, which is not sold in the U.S. It allows healthcare providers to monitor infusion data sent from Alaris Plus and Alaris neXus pumps on a computer. BD said in the notice that it communicates with customers about cybersecurity vulnerabilities,
